A cell-free protein-synthesizing system from Streptomyces fradiae was developed by preparing ribosomes and an S-150 fraction with precautions to prevent protease action. Using this system, the ribosomes of this organism were shown to be susceptible to its own product, neomycin.
I N T R O D U C T I O N
Neomycin inhibits protein synthesis in sensitive bacteria. The neomycin-producing Streptomyces fradiae possesses the same type of ribosomes (70s) as sensitive bacteria, but it has not previously been determined whether the ribosomes of S. fradiae are sensitive or resistant to neomycin. In this paper, the sensitivity of the ribosomes of S. fradiae to neomycin was investigated using an in-vitro system which we have developed. HUT6096 (IMRU 3554) was used as a neomycin-producing strain and was grown in the medium described by Majumdar & Majumdar (1969) at 28°C until the mid-exponential phase of growth.
METHODS

Micro-organism. Streptomyces fradiae
Preparation of the ribosomes and the S-150 fraction. The harvested cells were washed twice with buffer I [lo mM-Tris/HCl (pH 7-65), 30 m-NH,CI, 10 mM-magnesium acetate and 6 m~-2-mercaptoethanol], then ground with quartz sand and extracted with similar buffer containing 2 pug deoxyribonuclease I ml-l. The extract was centrifuged at 30000g for 30 min. From the supernatant, the ribosomes were sedimented by centrifugation at 150000g for 3 h, then washed with buffer I1 [20m-Tris/HC1 (pH 7*65), 1 M-NH,CI, 10 mM-magnesium acetate, 6 m-Zmercaptoethanol and 1.1 ~-sucrose] by the methods of Fahnestock et af. (1974) . The 150000 g supernatant fluid was dialysed against buffer I and used as the S-150 fraction.
Assay of protein synthesis in vitro. The reaction mixture and conditions for assay of polyphenylalanine synthesis were the same as those described by Kobayashi et aE. (1977) except that spermidine and the 19 amino acids other than phenylalanine were present at 0.4 m and 0.004 mM, respectively. The tRNA was derived from Escherichia coli MREGOO (Boehringer) .
RESULTS A N D DISCUSSION
When polyphenylalanine-synthesizing activity was measured in vitro using the ribosomes and tbe S-150 fraction from S. fradiae, no activity was detected (results not shown).
In Streptomyces griseus, we previously found (Sugiyama et al., 1980 ) that polyphenylalanine synthesis by the ribosomes and the S-150 fraction was inhibited by a protease produced by the organism itself. By eliminating the protease activity from these two fractions, polyphenylalanine synthesis was successfully observed.
Protease activity was eliminated from the ribosomes and the S-150 fraction of S. fradiae by adding 5 m~-EDTA KzMg salt, 3.45 mM-phenylmethylsulphonyl fluoride and 0.2 ~IMdi-isopropyl fluorophosphate to buffer I and buffer I1 as described in the earlier experiments (Sugiyama et al., 1980) . However, in the present experiments the ribosomes and the S-150 fraction were dialysed against buffer I just before use for polyphenylalanine synthesis, whereas in the earlier experiments the buffer for dialysis contained the above protease inhibitors. AS shown in Fig. 1, polyphenylalanine synthesis by the ribosomes and the S-150 fraction of S. fradiae was clearly observed, showing that protease was probably an inhibitory factor in this in-vitro protein-synthesizing system also. Furthermore, polyphenylalanine synthesis was obviously inhibited by neomycin, showing an inhibition of approximately 70 % by 100 ,ug neomycin ml-l after 30 min incubation at 37 "C. From these results, we conclude that the ribosomes of S. fradiae are susceptible to neomycin. In S. griseus, polyphenylalaniae synthesis by cell-free systems prepared from exponential phase cells and also stationary phase cells was shown to be susceptible to streptomycin. Aminoglycoside antibiotic-producing Streptomyces seem to have some mechanism of resistance against their products other than the ribosomal resistance.
